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Introduction
The archetypical protein modifi  er ubiquitin is a ubiquitously 
expressed, highly conserved polypeptide best known as a 
marker for intracellular protein turnover (Varshavsky, 2005). 
Proteasomal degradation of proteins is generally preceded 
by  covalent tagging of proteins with a ubiquitin polymer 
(Hershko and Ciechanover, 1998). Ubiquitin tagging is the re-
sult of an enzymatic cascade executed by a ubiquitin-activating 
enzyme (E1), ubiquitin-conjugating enzymes (E2), and 
  ubiquitin-ligating enzymes (E3; Pickart, 2001). The E1, E2, 
and some E3 enzymes form a thiolester linkage with ubiquitin, 
which is eventually conjugated by an isopeptide bond either to 
an internal lysine residue or to the free NH2 terminus of a 
 target  protein.
Ubiquitylation plays a critical role in many other cellular 
events as well (Aguilar and Wendland, 2003). Histones were the 
fi  rst ubiquitin-modifi  ed proteins to be identifi  ed and are the pre-
dominant ubiquitin targets in the nuclei of metazoans (Hunt and 
Dayhoff, 1977). Ubiquitylated histone H2A (uH2A) is required 
for gene silencing (de Napoles et al., 2004; Wang et al., 2004; 
Baarends et al., 2005). The internalization of receptors and the 
delivery of proteins to the multivesicular bodies are also depen-
dent on ubiquitylation (Di Fiore et al., 2003).
Although the roles of ubiquitin in these processes have 
been studied in detail, the dynamic exchange of ubiquitin be-
tween these different systems is less well understood. We fol-
lowed the dynamics of fl  uorescently tagged ubiquitin in living 
cells and showed that histones and other ubiquitin substrates 
compete for a limited pool of free ubiquitin. This links ubiquitin -
dependent processes, coupling protein degradation to chro matin 
remodeling, and adds a dynamic dimension to ubiquitin as a 
general regulator of the cellular proteome.
Results and discussion
We generated a construct encoding wild-type ubiquitin with 
an NH2-terminal GFP tag. It has been recently shown that 
GFP–ubiquitin (GFP-Ub) fusions are functionally conjugated 
to substrates and show similar localization as endogenous 
ubiquitin (Qian et al., 2002). A similar fusion was made with 
a conjugation-defi  cient mutant ubiquitin lacking all internal 
lysine residues and the COOH-terminal glycine residue 
(GFP-Ub
K0,G76V). Western blot analysis of the total lysates of 
human melanoma Mel JuSo cells stably expressing these 
fusions confi  rmed that GFP-Ub was present both as free mono-
mers ( 33 kD) and in large ubiquitin conjugates, whereas 
GFP-Ub
K0,G76V was exclusively found as free monomers (Fig. 
1 A, left). Importantly, comparing the signals that were  obtained 
when both the parental and stable Mel JuSo cell   lysates were 
probed with the antiubiquitin antibody showed that GFP-Ub 
and GFP-Ub
K0,G76V were expressed in minute amounts compared 
with endogenous ubiquitin (Fig. 1 A, right). Under nonreducing 
A dynamic ubiquitin equilibrium couples 
proteasomal activity to chromatin remodeling
Nico P. Dantuma,
1 Tom A.M. Groothuis,
2 Florian A. Salomons,
1 and Jacques Neefjes
2
1Department of Cell and Molecular Biology, The Medical Nobel Institute, Karolinska Institutet, S-171 77 Stockholm, Sweden
2Division of Tumor Biology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, Netherlands
rotein degradation, chromatin remodeling, and 
membrane trafﬁ   cking are critically regulated by 
ubiquitylation. The presence of several coexisting 
ubiquitin-dependent processes, each of crucial importance 
to the cell, is remarkable. This brings up questions on 
how the usage of this versatile regulator is negotiated be-
tween the different cellular processes. During proteotoxic 
stress, the accumulation of ubiquitylated substrates coin-
cides with the depletion of ubiquitylated histone H2A and 
chromatin remodeling. We show that this redistribution of 
ubiquitin during proteotoxic stress is a direct consequence 
of competition for the limited pool of free ubiquitin. Thus, 
the ubiquitin cycle couples various ubiquitin-dependent 
processes because of a rate-limiting pool of free ubiquitin. 
We propose that this ubiquitin equilibrium may allow cells 
to sense proteotoxic stress in a genome-wide fashion.
N.P. Dantuma and T.A.M. Groothius contributed equally to this paper.
Correspondence to Nico P. Dantuma: nico.dantuma@ki.se; or Jacques Neefjes: 
j.neefjes@nki.nl
Abbreviations used in this paper: GFP-Ub, GFP-ubiquitin; PAGFP, photoactivatable 
GFP; uH2A, ubiquitylated histone H2A.
The online version of this article contains supplemental material.
PJCB • VOLUME 173 • NUMBER 1 • 2006  20
conditions, the levels of free GFP-Ub and ubiquitin were 
lower, suggesting that a major fraction of the monomeric 
GFP-Ub and ubiquitin is not free, but covalently linked by 
  reducible thiolester linkage to ubiquitylation enzymes (Fig.1 A). 
We consistently found that fewer ubiquitin conjugates were 
recovered under nonreducing conditions, which may be 
caused by poorer solubility of the conjugates in the absence of 
reducing agents.
Microscopic analysis of living cells showed that GFP-Ub 
was present in both nucleus and cytosol. Although GFP-Ub
K0,G76V 
was equally distributed throughout the cytosolic and nuclear 
compartments, GFP-Ub levels were highest in the nucleus, 
where it displayed a punctuate staining with irregular granular 
dots, and was lower in the nucleoli (Fig. 1 B). In the cytosol, 
GFP-Ub was distributed in a diffuse pattern and associated with 
a large number of mobile punctuate structures (Fig. 1 C, top), 
of which many appear to be lysosomes (Fig. 1 C, bottom). 
The staining that was obtained with a ubiquitin-specifi  c anti-
body matched the GFP fl  uorescence in GFP-Ub–expressing Mel 
JuSo cells (Fig. 1 D). Notably, because GFP-Ub forms only a 
small fraction of the total ubiquitin pool in these cells, GFP-Ub 
apparently distributes like endogenous ubiquitin.
The ubiquitin–proteasome system was functional in the 
presence of the GFP–Ub fusions because the cell cycle distri-
bution pattern and the cell surface expression of stable   major 
histocompatibility class I molecules (Fig. S1, available at 
http://www.jcb.org/cgi/content/full/jcb.200510071/DC1), two 
events that strongly depend on ubiquitylation machinery that is 
intact, were not affected.
Our biochemical analysis (Fig. 1 A) and that of others 
(Carlson et al., 1987; Mimnaugh et al., 1997) suggested that 
cells contain only a limited pool of free ubiquitin. To test this in 
living cells, we took advantage of the fact that the molecular 
mass of free monomeric GFP-Ub is 33 kD, which allows pas-
sive diffusion through the nuclear pore (Talcott and Moore, 1999), 
unless it is incorporated into larger complexes. We photo-
bleached GFP-Ub and GFP-Ub
K0,G76V in the cytosol or nucleus 
and quantifi  ed the redistribution of fl  uorescence from the non-
bleached compartment in a fl  uorescence loss in photobleaching 
protocol, basically using the nuclear pore as a molecular sieve 
Figure 1.  Generation and characterization of 
cell lines for in vivo monitoring of ubiquitin. 
(A) Western blot analysis of cell lysates of 
  parental Mel JuSo cells and Mel JuSo cells 
stably expressing GFP-Ub or GFP-Ub
K0,G76V. 
The samples were separated under reducing 
and nonreducing conditions and probed with 
an anti-GFP antibody (left) and an antiubiqui-
tin antibody (right). The blots were reprobed 
with an anti–glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH) antibody to check for 
protein loading. (B) Micrographs of living 
GFP-Ub and GFP-Ub
K0,G76V cells. (C) Fluores-
cence micrographs of live GFP-Ub cells stained 
with LysoTracker red. GFP ﬂ  uorescence (left), 
LysoTracker ﬂ  uorescence (middle), and merged 
images (right) are shown. (bottom) Magniﬁ  ca-
tion of the boxed regions. (D) Mel JuSo cells 
expressing GFP-Ub were stained with the 
ubiquitin-speciﬁ   c antibody FK2. Native GFP 
ﬂ   uorescence, antiubiquitin staining, a DAPI 
nuclear staining, and the merge of the three 
images are shown. Bars, 10 μm.THE UBIQUITIN EQUILIBRIUM • DANTUMA ET AL. 21
to distinguish free from conjugated GFP-Ub molecules (Koster 
et al., 2005). GFP-Ub displayed biphasic redistribution between 
the two compartments, with a fast component in the fi  rst minute 
followed by a major slow component (Fig. 2, A and B). The 
presence of a small fraction that is rapidly exchanged during the 
fi  rst minute is in agreement with a small amount of free mono-
meric GFP-Ub, as detected biochemically (Fig. 1 A). The slow 
exchange persisted with similar kinetics throughout the record-
ing, suggesting the continuous generation of freely diffus-
ing    GFP-Ub. Rapid redistribution was observed with the 
GFP-Ub
K0,G76V, with a complete exchange of fl  uorescence within 
6 min confi  rming that this monomeric form effi  ciently diffuses 
through the nuclear pore (Fig. 2, C and D).
The slow exchange of GFP-Ub between the nuclear and 
cytosolic compartments suggests that the vast majority of ubiq-
uitin is incorporated into large complexes that cannot pass the 
nuclear pore. We performed FRAP analysis, which allows de-
termination of protein diffusion and mobility rates (Reits and 
Neefjes, 2001). The Brownian motion of particles is related to 
their size, and large polyubiquitin complexes are thus expected 
to diffuse considerably slower than free ubiquitin. For compari-
son, we included a Mel JuSo cell line expressing a GFP-tagged 
α3 subunit of the proteasome, which is a large, freely diffusible 
complex (Reits et al., 1997). Coimmunoprecipitation and 
  sucrose gradient experiments confi  rmed that the α3 subunit is 
incorporated into the proteasome particle (unpublished data). 
FRAP analysis revealed both the diffusion rate and the fraction 
of mobile proteins. A large portion was mobile in the cytosol, 
unlike GFP-Ub in the nucleus, which is where the majority of 
GFP-Ub was immobile (Fig. 3, A and B). Quantitative analysis 
of the FRAP data revealed a much larger fraction of immobile 
nuclear GFP-Ub, as compared with the cytosolic GFP-Ub 
(Fig. 3 C). An immobile GFP-Ub fraction in the cytosol is likely 
to be a consequence in part of the role of ubiquitin in membrane 
traffi  cking (Di Fiore et al., 2003). Moreover, ubiquitylated pro-
teins can bind to cytoskeletal-associated proteins (Kawaguchi 
et al., 2003) and form cytosolic clusters (Bjorkoy et al., 2005). 
Some 70% of GFP-Ub is immobile in the nucleus, which sup-
ports the notion that a major fraction of GFP-Ub is conjugated 
to histones (see Fig. 4).
The monomeric GFP-Ub
K0,G76V diffused rapidly through 
the cytosol and nucleus, whereas the GFP-tagged proteasome 
moved relatively slow in both compartments, in line with their 
size differences. Consistent with the notion that ubiquitin is in-
corporated in large ubiquitin chains (Hershko and Ciechanover, 
1998), the GFP-Ub pool had a surprisingly slow diffusion rate 
in the nucleus and cytosol, especially when compared with the 
proteasome (Fig. 3 D).
Biochemical analysis has revealed that proteasome inhibitor 
treatment and heat shock can deplete histones from ubiquitin 
(Carlson et al., 1987; Mimnaugh et al., 1997). To reveal the dy-
namics of this process, we monitored GFP-Ub in living cells 
after the administration of the proteasome inhibitor MG132. 
A rapid accumulation of GFP-Ub in the cytosol and the forma-
tion of aggresomes in the perinuclear region were observed 
within 2 h, which was accompanied by a profound loss of nuclear 
Figure 2.  Limited exchange of ubiquitin between nuclear and cytosolic compartments. (A) GFP-Ub cells were photobleached in either the complete cytosol 
(top) or the complete nucleus (bottom) and recovery was measured in both compartments. (B) Quantiﬁ  cation of the photobleaching experiments with 
GFP-Ub cells. The ratios of nuclear ﬂ  uorescence to cytosolic ﬂ  uorescence are plotted for cytosolic bleaching (shaded circles) and nuclear bleaching (open 
circles). (C) GFP-Ub
K0,G76V cells were photobleached in either the complete cytosol (top) or the complete nucleus (bottom) and recovery was measured in 
both compartments. (D) Quantiﬁ  cation of the photobleaching experiments with GFP-Ub
K0,G76V cells. The relative ratios of nuclear ﬂ  uorescence to cytosolic 
ﬂ  uorescence are plotted for cytosolic bleaching (shaded circles) and nuclear bleaching (open circles). Bars, 20 μm.JCB • VOLUME 173 • NUMBER 1 • 2006  22
GFP-Ub (Fig. 4 A).  Staining of fi  xed cells with the ubiquitin-
specifi   c FK2 antibody revealed a similar redistribution of 
  endogenous ubiquitin (Qian et al., 2002; unpublished data). 
During the 2-h inhibitor treatment, we observed a steady and 
gradual decline in nuclear GFP-Ub, coinciding with an increase 
in cytosolic fl  uorescence (Fig. 4 B). FRAP analysis demon-
strated that the mobile pool of GFP-Ub in the nuclear and cyto-
solic compartment was further decelerated by the inhibitor 
treatment (Fig. 4 C), which correlated with an accumulation of 
ubiquitin conjugates, as well as with a shift of the conjugates to 
higher molecular masses (Fig. 4 D). Both an increase in the 
amount of polyubiquitylated proteins, as well as an increase in 
the size of the polyubiquitin changes, is likely responsible for 
the reduced velocity of ubiquitin in MG132-treated cells. 
Notably, in the presence of MG132, the diffusion was reduced to
velocities that were in the same range as proteasomes, empha-
sizing the considerable size of these polyubiquitin complexes 
or direct association with proteasomes (compare Fig. 3 B and 
Fig. 4 C). The putative GFP-Ub–modifi  ed histones were only 
found in the nucleus and strongly declined during inhibitor 
treatment (Fig. 4 D). A similar reduction in the GFP-Ub– histone 
band was observed during heat shock, which is another form of 
proteotoxic stress, although under this condition polyubiquity-
lated material primarily accumulated in the nucleus (Fig. 4 D). 
A gradual redistribution of endogenous ubiquitin from the nu-
clear to the cytosol compartment was also evident when lysates 
of cells harvested at various times after inhibitor administration 
were probed with a ubiquitin-specifi  c antibody (Fig. S2, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200510071/DC1). 
Notably, proteasome inhibitor treatment reduced the nuclear 
immobile pool of GFP-Ub, which is in line with a reduction 
in histone-conjugated ubiquitin (Fig. 4 E). Western blot analy-
sis confi  rmed a decrease in endogenous uH2A levels under 
these stress conditions that was analogous to GFP-Ub–histone 
(Fig. 4 F). To further test whether GFP-Ub correctly refl  ected 
the behavior of endogenous ubiquitin in the process of MG132-
driven histone deubiquitylation, cells were incubated with 
MG132 and histones were analyzed at various periods   after 
proteasome inhibition. Both GFP-Ub–histone and uH2A were 
quantifi  ed and followed similar kinetics of deubiquitylation 
(Fig. 4, G and H). Half of the histones had released   ubiquitin 
or GFP-Ub  30 min after proteasome inhibition. Chromatin of 
proteasome inhibitor–treated and heat-shocked cells was less 
sensitive to staphylococcal nuclease (Fig. S3), suggesting a 
general condensation of nucleosomes that is similar to what 
has been observed previously for cells subjected to heat shock 
(Levinger and Varshavsky, 1982).
To gain insight into the mechanism responsible for de-
pletion of uH2A, we followed the redistribution of ubiquitin 
during proteotoxic stress in living cells. The GFP in the fusion 
constructs was replaced by a photoactivatable GFP (PAGFP; 
Patterson and Lippincott-Schwartz, 2002), and PAGFP-Ub was 
photoactivated in a confi  ned region in the nucleus (Fig. 5 A 
and Video 1, available at http://www.jcb.org/cgi/content/full/
jcb.200510071/DC1). Although most of the fl  uorescence was 
maintained in the photoactivated region, a small fraction of 
the photoactivated PAGFP-Ub immediately diffused to other 
Figure 3.  Dynamics of ubiquitin in nucleus and cytosol. (A) FRAP curves 
for GFP-Ub in the nucleus (black line) and cytoplasm (gray line). Mobile 
fractions (R) are indicated for both nuclear (dark gray) and cytoplasmic 
bleached area (light gray). The interpolations for the t1/2 are indicated 
with dashed lines in the same respective gray values. (B) Confocal   images 
of a FRAP experiment in the nucleus (top) or in the cytoplasm (bottom) 
  before, immediately after, and 25 s after a 2-s photobleaching. Bars, 
10 μm. (C) Mobile fractions (R) of GFP-Ub
K0,G76V, GFP-Ub, and protea-
some α3-GFP in stably transfected Mel JuSo cells. Diffusion was   measured 
in both the nucleus (black bars) and the cytoplasm (gray bars). Error bars 
are SD (n  > 10). (D) Diffusion rates of GFP-Ub
K0,G76V, GFP-Ub, and 
α3-GFP in stably transfected Mel JuSo cells. Diffusion was measured in 
both the nucleus (black bars) and the cytoplasm (gray bars). Error bars 
are SD (n > 10).THE UBIQUITIN EQUILIBRIUM • DANTUMA ET AL. 23
Figure 4.  Accumulation of polyubiquitylated 
  proteins coincides with depletion of uH2A and 
chromatin remodeling. (A) Fluorescence images of 
living GFP-Ub cells before and after 2 h incubation 
with 25 μM MG132. Bar, 10 μm. (B) Quantiﬁ  cation 
of GFP-Ub levels in the cytoplasm (open circles) 
and nucleus (closed squares) during proteasome 
inhibition with 25 μM MG132. Black line is the 
ratio of the nucleus to the cytoplasm as plotted on 
the left y axis. The relative ﬂ  uorescence of the nu-
cleus and cytoplasm is plotted on the right y axis. 
(C) Diffusion rates of GFP-Ub in nucleus and cyto-
plasm without treatment (black bars) and after 2 h 
of MG132 treatment (gray bars). P values are in-
dicated (unpaired t tests). Error bars represent the 
mean and SD of 15 independent cells in one rep-
resentative experiment. (D) Western blot analysis 
of nuclear (N) and cytosolic (C) fractions of GFP-Ub 
cells. Cells were left untreated or treated for 2 h 
with DMSO, MG132, or a heat shock, and nu-
clear (N) and cytosolic (C) fractions were isolated. 
Nuclear fractions contained, on average, two 
times less protein than the cytosolic fractions. For 
analysis, 15- and 30-μg proteins were loaded for 
the nuclear and cytosolic fractions, respectively. 
Membranes were probed with an anti-GFP anti-
body. Molecular mass markers are indicated. 
(E) FRAP curves for GFP-Ub in the nucleus of untreated 
cells (black line) and after 2 h incubation with 
MG132 (gray line). (F) Western blot analysis of 
uH2A in GFP-Ub cells left untreated or exposed for 
2 h to DMSO, MG132, or a heat shock. The mem-
branes were probed with an anti-uH2A antibody. 
Molecular mass markers are indicated. (G) Lysates 
of Mel JuSo cells expressing GFP-Ub that were 
treated for various time periods with MG132 were 
probed with an anti-GFP antibody (top) and uH2A 
antibody (bottom). (H) Quantiﬁ  cation of two inde-
pendent experiments as shown in G. The values 
of experiment 1 (circles), experiment 2 (diamonds), 
and the mean of the two experiments (bars) shown. 
The values were standardized to the intensities of 
the corresponding band in untreated cells. Deubiq-
uitylation of GFP-Ub–histone and uH2A followed 
similar kinetics.JCB • VOLUME 173 • NUMBER 1 • 2006  24
  regions in the nucleus, probably because of rapid redistribution of 
a small pool of free PAGFP-Ub (Fig. 2, A and B). Subsequently, 
fl   uorescence slowly appeared in the cytosolic compartment 
  coinciding with a gradual decrease in nuclear fl  uorescence. 
The fl  uorescent PAGFP-Ub distributed homogenously in the 
cytosol and on intracellular punctuate structures. In line with 
the notion that the vast majority of nuclear PAGFP-Ub was 
  conjugated to histones, PAGFP-Ub only slowly disappeared 
from the photoactivated region in the nucleus. We monitored 
the disappearance of the immobile PAGFP-Ub as a measure 
for histone deubiquitylation. Administration of proteasome in-
hibitor did not affect the rate of disappearance of the immobile 
nuclear PAGFP-Ub from the photoactivated region (Fig. 5 B), 
which suggests that the rate of histone deubiquitylation is not 
altered by proteasome inhibition.
Alternatively, the redistribution of ubiquitin may be the 
result of competition of two classes of ubiquitin substrates, i.e., 
proteasome substrates and histones, for the rate-limiting pool of 
free ubiquitin. If the loss of histone-conjugated ubiquitin in the 
nucleus is the result of limiting free ubiquitin levels, experi-
mental introduction of another ubiquitin competitor should have 
a similar effect. Indeed, microinjection of a GFP-specifi  c anti-
body in the cytosol of GFP-Ub–expressing cells caused the 
  accumulation of GFP-Ub in the cytosol and the depletion of 
  nuclear GFP-Ub, which is very similar to proteotoxic stress 
(Fig. 5, C and E). An irrelevant antibody did not affect the 
  distribution of GFP-Ub (Fig. 5, D and E). These data show that 
changes in the ubiquitin equilibrium can dramatically affect 
various ubiquitin-dependent processes.
Our data reveal a new dimension of ubiquitin-dependent 
regulation as the result of a delicate ubiquitin equilibrium 
(Fig. 5 F). This ubiquitin equilibrium may be a refl  ection of 
the constraints of the heavily used ubiquitylation system by 
various ubiquitin-dependent processes. Alternatively, changes 
in the cellular proteome as a consequence of the depletion of 
ubiquitylated histones may aid the cellular stress response. 
It has been shown that the decrease in the levels of ubiquitylated 
histones during proteotoxic stress causes major changes in 
gene expression (Carlson et al., 1987; Mimnaugh et al., 1997). 
In fact, the depletion of ubiquitylated histones is a rapid 
  response, and the fi  rst changes can already be observed within 
5 min. Cellular stress is apparently rapidly translated into chro-
matin alterations, which are likely to affect gene expression. 
Cross-talk between these ubiquitin-dependent processes by 
means of limiting free ubiquitin levels may be of functional 
signifi  cance, as it may integrate diverse mechanisms in the 
combined effort to adapt the cellular proteome to the altering 
intracellular environment.
Figure 5. Competition for free ubiquitin 
causes depletion of uH2A during proteotoxic 
stress. (A) Confocal images of PAGFP-Ub in 
Mel JuSo cells before photoactivation (Pre) 
and three time points after photoactivation 
(0, 200, and 1,200 s). In the image before 
activation (Pre), the contours of the cell (C), the 
nucleus (N), and the region to be activated (A) 
are indicated. The look-up table is provided on 
the right (see also Video 1). (B) Quantiﬁ  cation 
of ﬂ  uorescence in an activated nuclear region 
visualizes the decay of PAGFP-Ub before and 
after the addition of MG132. PAGFP ﬂ  uores-
cence is depicted with the blue line, whereas 
trend lines derived from similar experiments 
with untreated or MG132-treated cells are 
shown in red and green, respectively. (C) Con-
focal images of GFP-Ub cells injected with 
dextran–Texas red and anti-GFP antibody or 
(D) injected with dextran–Texas red and anti-
mCD27 antibody. (E) Quantiﬁ   cations of the 
relative ﬂ  uorescence ratio between the nucleus 
and the cytoplasm in control, anti-mCD27–
  injected, anti-GFP–injected, or MG132-treated 
cells. Error bars are standard deviations (n > 50). 
(F) Schematic representation of the dynamic 
ubiquitin equilibrium in the cell. Video 1 is 
available at http://www.jcb.org/cgi/content/
full/jcb.200510071/DC1. Bars: (A) 10 μm; 
(C and D) 20 μm.THE UBIQUITIN EQUILIBRIUM • DANTUMA ET AL. 25
Materials and methods
Cell culture and constructs
Wild-type Ub and the Ub
K0,G76V mutant were cloned into EGFP-C1 vector 
(CLONTECH Laboratories, Inc.) and PAGFP-C1 vector (gift from J. Lippincott-
Schwarz, National Institutes of Health, Bethesda, MD) and transfected into 
the human melanoma cell line Mel JuSo. Stable cell lines were generated 
under the selection of 1 mg/ml neomycin containing Iscove’s DME supple-
mented with penicillin/streptomycin and 8% FCS (Invitrogen). For live cell 
imaging, cells were either cultured on 24-mm glass coverslips or cultivated 
in 0.17-mm Delta T dishes (Bioptechs). Before microscopic analysis, the 
culture medium was covered with a thin layer of mineral oil (Sigma-Aldrich) 
to prevent evaporation of the medium during recording. Lysosomes were 
stained by incubating cells with 50 nM LysoTracker red (Invitrogen). 
The proteasome inhibitor MG132 (Sigma-Aldrich) was dissolved in DMSO 
and used at a 25-μM concentration, unless otherwise stated. Heat shock 
was induced by incubating the cells for 3 h at 42°C.
Immunostainings
Cells were cultured on 15-mm glass coverslips, ﬁ  xed with 3.7% formalde-
hyde for 10 min at room temperature, permeabilized with 0.5% Triton 
X-100 for 2 min, and immunostained in phosphate-buffered saline with 
0.5% bovine serum albumin. FK2 antibody (Afﬁ  nity BioReagents, Inc.) was 
used at a ratio of 1:1,000. 2 ng/ml DAPI (Sigma-Aldrich) was added 
  during secondary antibody incubation with goat anti–mouse-TxR (Invitrogen).
Western blot analysis
Parental GFP-Ub, stable GFP-Ub, and GFP-Ub
K0,G76V Mel JuSo cells were 
washed with phosphate-buffered saline and trypsinized. Cells were lysed 
in SDS-PAGE sample buffer. Proteins were separated by SDS-PAGE, trans-
ferred onto nitrocellulose or PVDF membranes, and probed with two differ-
ent rabbit polyclonal antibodies against GFP (Invitrogen; van Ham et al., 
1997) or a rabbit polyclonal antibody against ubiquitin (DakoCytomation 
and Sigma-Aldrich, respectively). The ﬁ  lters were reprobed with a mouse 
monoclonal antibody against glyceraldehyde-3-phosphate dehydrogenase 
(Fitzgerald Industries, Intl.) as a control for equal protein loading. After in-
cubation with peroxidase-conjugated secondary antibodies, the blots were 
developed by enhanced chemiluminescence (GE Healthcare).
For separation of nuclei and cytosol, cells were scraped in a buffer 
containing 100 mM NaCl, 300 mM sucrose, 3 mM MgCl2, 50 mM Hepes, 
pH 7.0, 1 mM EGTA, and 0.2% Triton X-100 supplemented with protease 
inhibitors and 50 mM N-ethylmaleimide. Cells were lysed for 10 min, and 
nuclei were pelleted by centrifugation for 5 min at 1,000 g. The superna-
tant is the cytosolic fraction; nuclei were resuspended in a buffer contain-
ing 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 0.1% SDS supplemented 
with 50 mM N-ethylmaleimide and sonicated on ice to disrupt DNA.
Live cell imaging
For ﬂ  uorescence loss in photobleaching experiments, Mel JuSo cells were 
cultured in 0.17-mm Delta T dishes (Bioptechs). Confocal laser scanning 
microscopy was performed with an LSM 510 META with a Plan-Apochromat 
63× oil objective, NA 1.4 (both Carl Zeiss MicroImaging, Inc.), equipped 
with a cell culture stage (Bioptechs) at 35°C. After photobleaching of the 
GFP ﬂ  uorescence by exposure of selected regions to 488-nm laser with 
100% intensity for 30 iterations, images were obtained every 10 s during 
a time frame of 4 min, followed by 10 images during a time frame of 10 min. 
Images were processed using the LSM software. Fluorescence intensities 
were measured using ImageJ software (National Institutes of Health). 
The relative ﬂ   uorescence ratio between the nucleus and cytoplasm was 
  averaged from three recordings. For line-scan FRAP experiments, we used 
a confocal system (TCS SP2; Leica) equipped with an external bleaching 
  laser and a heating ring to keep the cells at 37°C. PAGFP-Ub was tran-
siently expressed in Mel JuSo cells. In the photoactivation step, PAGFP was 
activated by applying a single pulse to a small region in the cell with 405-nm 
laser light at full intensity. For photoactivation experiments, we used a 
TCS SP2 AOBS system equipped with HCX PL APO and HCX PL APO 
lbd.bl 63× objective lenses, both with an NA of 1.4 (all Leica). Quantiﬁ  ca-
tion was done with physiology software version 2.61 (Leica). FRAP data 
was analyzed as previously described (Reits and Neefjes, 2001).
Antibody injection
For antibody injection, cells were seeded on 15-mm glass coverslips. Cells 
were microinjected with a mixture containing 1 mg/ml lysine-  ﬁ  xable 70-kD 
Dextran–Texas red (Invitrogen) and 1 mg/ml of puriﬁ  ed polyclonal rabbit 
anti-GFP antibody (van Ham et al., 1997) or puriﬁ  ed polyclonal rabbit 
anti-mCD27 (gift from J. Borst, The Netherlands Cancer Institute, Amsterdam, 
Netherlands). Microinjections were done on an inverse epiﬂ  uorescence 
microscope (Axiovert 200; Carl Zeiss MicroImaging, Inc.) equipped with 
a manipulator 5171/transjector 5246 system (Eppendorf) and a 37°C 
heated ring. After microinjection, cells were cultured for another 2 h and 
ﬁ  xed with 3.7% formaldehyde for 10 min at room temperature.
Online supplemental material
Fig. S1 shows the analysis of functionality for the ubiquitin–proteasome 
system, Fig. S2 shows changes in ubiquitin distribution during proteasome 
inhibitor treatment, Fig. S3 shows changes in nucleosome condensation 
during proteotoxic stress, and Video 1 shows the distribution of PAGFP-Ub 
after photoactivation. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.200510071/DC1.
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